Industries > Pharma > Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Financial Performances, Services, Capacities, Mergers & Acquisitions, SWOT Analysis

PUBLISHED: 28 September 2018
PAGES: 257
PRODUCT CODE: PHA0334
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the benefits of contract manufacturing – lower costs, increased flexibility and external expertise – to focus resources on core competencies in drug development and marketing.

CMOs are increasingly seen as a strategic partner for pharmaceutical companies, providing a one-stop-shop of services for formulation development and manufacturing throughout the lifecycle of a drug.

The market-leading CMOs have grown through acquisitions and site expansions to offer almost all required services on a global scale. However, there is still a role to be played by specialist CMOs, particularly those that offer biological drug manufacturing services.

This updated study discusses market-leading companies worldwide, as well as the strategies they have employed to develop in recent years. Visiongain’s research and analysis explore opportunities and challenges for the top 50 pharma contract manufacturing organisations.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 257-page report you will receive 189 charts– all unavailable elsewhere.

The 257-page report provides clear detailed insight into the leading pharmaceutical contract manufacturing organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• Global Pharmaceutical Contract Manufacturing Market Size in 2017

• Pharmaceutical Contract Manufacturing Market Size in 2017 segmented by national market:
• US
• EU
• China
• Japan
• India
• Brazil
• Russia
• South Korea
• Others

• Discussion and analysis of factors that drive and restrain the pharmaceutical contract manufacturing market

• Profiles of the 50 leading pharmaceutical contract manufacturing organizations:
• AbbVie Contract Manufacturing
• Aenova Group
• Aesica Pharmaceuticals
• Ajinomoto Althea, Inc.
• Albany Molecular Research, Inc.
• Alcami Corporation
• Alkermes plc
• Almac Group
• Amatsigroup
• Aurobindo Pharma Ltd.
• Avid Bioservices Inc.
• Bayer AG
• Baxter Biopharma Solutions
• Biomay AG
• Boehringer Ingelheim GmbH
• Catalent Pharma Solutions Inc.
• Charles River Laboratories International Inc.
• Cardinal Health
• Corden Pharmaceutical
• Daito Pharmaceutical
• Delpharm
• Divis Laboratories Ltd.
• Dr. Reddy’s Laboratories Ltd.
• DPT Laboratories
• Esteve Química
• Evonik Degussa
• Famar Health Care Services
• Fareva
• Fujifilm Diosynth Biotechnologies UK Ltd.
• GlaxoSmithKline plc
• Huapont Medical
• Lonza Group Ltd.
• Nipro Corporation
• Paragon Bioservices Inc
• Patheon Inc
• Pfizer Inc./Pfizer CentreSource (PCS)
• Piramal Healthcare L
• Recipharm A
• Roche
• Royal DSM NV
• Shandong Xinhua Pharmaceutical
• Siegfried
• Teva API
• Therapure Biopharma Inc.
• UPM Pharmaceuticals Inc.
• Vetter Pharmacuticals
• Xcelience LLC
• Xcellerex LLC
• Zhejiang Hisun Pharmaceutical
• Zhejiang Huahai Pharmaceuticals

Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• Overview of the company’s contract manufacturing services and operations
• Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth

Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical contract manufacturing market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018: Financial Performances, Services, Capacities, Mergers & Acquisitions, SWOT Analysis.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category